Document is current
Any future updates will be listed below
-
Authors
Kuznik, Andreas
Coughlan, Anna
Pinsent, Amy
Toro-Diaz, Hector
Sherman, Steven
Patel, Nimesh
-
Funding
Funding for this research was provided by:
Regeneron Pharmaceuticals
- License Information
-
More Information
Article History
Received: 11 July 2025
Accepted: 19 August 2025
First Online: 19 September 2025
Declarations
:
: Andreas Kuznik and Steven Sherman are employees and shareholders of Regeneron Pharmaceuticals, Inc. Anna Coughlan, Amy Pinsent, and Hector Toro-Diaz are employees of PPD Evidera, which received funding from Regeneron Pharmaceuticals, Inc. for conducting this analysis. Nimesh Patel has served as an advisor for Alcon, Alimera, Allergan, Apellis, Biogen, DORC, EyePoint, Genentech, Kyoto Drug Company, Regeneron Pharmaceuticals, Inc., and REGENXBIO.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals that were performed by any of the authors.
